4.6 Article

The upregulation of CLGN in hepatocellular carcinoma is potentially regulated by hsa-miR-194-3p and associated with patient progression

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

The positive feedback loop of NHE1-ERK phosphorylation mediated by BRAFV600E mutation contributes to tumorigenesis and development of glioblastoma

Yuhui Li et al.

Summary: The study identified NHE1 as a downstream target of BRAF(V600E) and an upstream factor of ERK, with a positive feedback loop between NHE1 and ERK phosphorylation promoting GBM cell proliferation and invasion. Both NHE1 inhibitor, BRAF(V600E) inhibitor, and their combination showed efficacy in suppressing the growth and invasion abilities of GBM cells, with the combination demonstrating the best results.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Review Oncology

Immunotherapies for hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, specifically hepatocellular carcinoma (HCC), is the second leading cause of cancer-related death globally. Traditional treatments involve specific drugs, but the emergence of immune checkpoint inhibitors has revolutionized the management of HCC.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Article Pathology

The emerging roles of NGS in clinical oncology and personalized medicine

Bashdar Mahmud Hussen et al.

Summary: Next-generation sequencing (NGS) has become increasingly popular in genomics studies due to advancements in sequencing technology. It is now being utilized in clinical oncology to improve cancer therapy through various approaches, including finding cancer mutations, identifying carriers of these mutations, and implementing personalized medicine. Personalized medicine has the potential to reduce medical expenses by shifting towards an individualized preventive and predictive approach. NGS can accelerate early disease diagnosis and discover pharmacogenetic markers that aid in personalized therapies. Additionally, NGS provides a more comprehensive understanding of cancer and uncovers pathways of cancer development.

PATHOLOGY RESEARCH AND PRACTICE (2022)

Review Oncology

Potential Biomarkers for Liver Cancer Diagnosis Based on Multi-Omics Strategy

Fanghua Chen et al.

Summary: Liver cancer is the fourth leading cause of cancer-related death worldwide, predominantly hepatocellular carcinoma (HCC). Only a small percentage of HCC patients are eligible for curative therapy due to the lack of early detection strategies. The integration of multi-omics technology offers the potential for identifying reliable biomarkers for HCC diagnosis.

FRONTIERS IN ONCOLOGY (2022)

Review Oncology

Recent advances in systemic therapy for hepatocellular carcinoma

Huajun Zhang et al.

Summary: Hepatocellular carcinoma (HCC) is a common and lethal malignancy worldwide. While therapeutic options for advanced HCC are limited, sorafenib has been the only proven effective systemic drug for more than a decade. However, the rapid progress of molecular targeted therapies in the past three years has significantly changed the treatment landscape for advanced HCC. The incorporation of immune checkpoint therapies and their combination with molecular targeted therapy are emerging tools to enhance the immune response.

BIOMARKER RESEARCH (2022)

Article Gastroenterology & Hepatology

Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism

Trung Vu et al.

Summary: The study revealed that STRAP plays a crucial role in Apc mutation/deletion-induced intestinal tumorigenesis through a novel feed-forward regulatory axis involving STRAP/MEK-ERK/Wnt-beta-catenin/STRAP. This indicates a potential therapeutic target for colorectal cancer associated with Apc gene mutations.

GASTROENTEROLOGY (2022)

Review Oncology

Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives

Maria Pallozzi et al.

Summary: The search for non-invasive biomarkers is crucial in modern oncology to evaluate patients' response to immunotherapy. The treatment perspectives of hepatocellular carcinoma (HCC) have significantly improved after the introduction of immunotherapy, but only a small portion of patients benefit from it. Therefore, finding accurate biomarkers to predict prognosis has become a hot topic of research.

CANCERS (2022)

Article Medicine, General & Internal

Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study

Linbin Lu et al.

Summary: This study aimed to characterize the trajectories of AFP after TACE and investigate their impact on clinical outcomes for intermediate-stage HCC. The results showed that different AFP trajectories were associated with clinical outcomes, with the high-rising trajectory linked to poorer survival and the sharp-falling trajectory associated with better survival.

ECLINICALMEDICINE (2022)

Article Oncology

Identification of STXBP6-IRF1 positive feedback loop in regulation of PD-L1 in cancer

Yanbin Liu et al.

Summary: The research identified a novel positive feedback loop between STXBP6 and IRF1 in regulating PD-L1 expression, which affects the response to immunotherapy targeting PD-L1 in cancer.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Article Oncology

Large-scale omics data reveal the cooperation of mutation-circRNA-miRNA-target gene network in liver cancer oncogenesis

Jian Li et al.

Summary: The study reveals that tumor-specific mutations may serve as the initial trigger of liver cancer, and the chain of mutations-circRNA-miRNA-target gene has been completed and validated through experimental verification.

FUTURE ONCOLOGY (2021)

Review Medical Laboratory Technology

Application of Next Generation Sequencing in Laboratory Medicine

Yiming Zhong et al.

Summary: This review discusses the rapid advancement of next-generation sequencing technology and its wide clinical applications in precision medicine, particularly in inherited diseases, oncology, and infectious diseases. It highlights the importance of NGS in clinical oncology, FDA-approved NGS panels, and the role of host microbiome in infectious diseases. The review also addresses the challenges and future prospects of clinical NGS tests.

ANNALS OF LABORATORY MEDICINE (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Immunology

Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression

Yingying Xing et al.

Summary: MiRNA plays multifarious roles in tumor progression by regulating the tumor immune microenvironment, impacting the function of immune cells and tumor cells. Investigating the role of miRNA can elucidate the mechanisms of interaction between immune cells and tumor cells, with potential use as a predictor of immune disorders in tumor progression.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Meiotic nuclear divisions 1 (MND1) fuels cell cycle progression by activating a KLF6/E2F1 positive feedback loop in lung adenocarcinoma

Quanli Zhang et al.

Summary: Research has identified that the up-regulation of MND1 in LUAD patients is an independent risk factor for overall survival, and its mechanism in promoting LUAD cell proliferation may be related to cell cycle regulation. Further experiments validated the interaction between MND1 and the tumor suppressor KLF6, forming a positive feedback loop to regulate the cell cycle and potentially have therapeutic effects on LUAD patients.

CANCER COMMUNICATIONS (2021)

Article Health Care Sciences & Services

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

Andras Lanczky et al.

Summary: The web-based tool introduced in this study enables univariate and multivariate Cox proportional hazards survival analysis using data from various genomic studies, filling a significant gap in the field where no commonly used spreadsheet software or web server is available for this purpose.

JOURNAL OF MEDICAL INTERNET RESEARCH (2021)

Review Pharmacology & Pharmacy

Deep learning in next-generation sequencing

Bertil Schmidt et al.

DRUG DISCOVERY TODAY (2020)

Review Gastroenterology & Hepatology

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Ju Dong Yang et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Multidisciplinary Sciences

miRWalk: An online resource for prediction of microRNA binding sites

Carsten Sticht et al.

PLOS ONE (2018)

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Review Genetics & Heredity

Endogenous microRNA sponges: evidence and controversy

Daniel W. Thomson et al.

NATURE REVIEWS GENETICS (2016)

Review Gastroenterology & Hepatology

The yin and yang of evasion and immune activation in HCC

Oxana V. Makarova-Rusher et al.

JOURNAL OF HEPATOLOGY (2015)

Article Biochemistry & Molecular Biology

Most mammalian mRNAs are conserved targets of microRNAs

Robin C. Friedman et al.

GENOME RESEARCH (2009)

Review Biochemistry & Molecular Biology

MicroRNAs: Genomics, biogenesis, mechanism, and function

DP Bartel

Article Biochemistry & Molecular Biology

Mnd1 is required for meiotic interhomolog repair

C Zierhut et al.

CURRENT BIOLOGY (2004)